PUBLIC COMPANY
saveKorsana Biosciences Inc
updated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Biotech reverse mergers rebound to highest level since 2021 as PIPEs flood market: reportReverse mergers have returned with a bang. More biotechs have taken the back door to the public markets so far in 2026 than in any full year since 2021, according to J.P. Morgan, with institutional…fiercebiotech · 11d ago
- Another Paragon spinout goes public through reverse mergerOne lawyer involved noted how it's yet another example of Paragon and key investor Fairmount — which have helped transform the reputation for reverse mergers — quickly executing on a complicated deal.biopharma_dive · 18d ago
- Novartis to pay $125M for blood-brain barrier crossing platformProceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup says have “best-in-class” potential.biopharma_dive · 1mo ago
- Chutes & Ladders—BioNTech brings in Sobi CEOAfter a six-month wait, BioNTech has finally filled its vacant CEO spot with Guido Oelkers, Ph.D. Oelkers hails from his tenure as CEO of Swedish pharma Sobi, where he oversaw the licensing of the…fiercebiotech · 2mo ago
comments(0)
5-min edit window · permanent after that